TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Novartis
Related studies linked through entity extraction aliases.
Withdrawal of Inhaled Corticosteroids in Primary Care Patients With COPD
- Status
- UNKNOWN
- Phase
- NA
Study of Everolimus as Maintenance Therapy for Metastatic NEC With Pulmonary or Gastroenteropancreatic Origin
- Status
- UNKNOWN
- Phase
- PHASE2
Pharmacological Reduction of Functional, Ischemic Mitral REgurgitation
- Status
- COMPLETED
- Phase
- PHASE4
Monitoring Chronic Urticaria Basophil Irritability by Cytometry
- Status
- COMPLETED
- Phase
- N/A
Pasireotide LAR and Pegvisomant Study in Acromegaly
- Status
- UNKNOWN
- Phase
- PHASE4
Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments
- Status
- COMPLETED
- Phase
- N/A
Rheumatic Heart Disease Study in Lusaka
- Status
- COMPLETED
- Phase
- N/A
Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo
- Status
- COMPLETED
- Phase
- NA
An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trastuzumab Or T-Dm1 For Advanced/Metastatic Her2-Positive Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Molecular Profiling and Matched Targeted Therapy for Patients With Unresectable Advanced or Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Buparlisib and Ofatumumab or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
A Phase I/II Study of Ribociclib,a CDK4/6 Inhibitor, Following Radiation Therapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Preoperative Ceritinib (LDK378) in Glioblastoma Multiforme and CNS Metastasis
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Study of Secukinumab for the Treatment of Alopecia Areata
- Status
- TERMINATED
- Phase
- PHASE2
Indacaterol in Heart Failure Patients: Any Role on Lung Fluid Regulation
- Status
- COMPLETED
- Phase
- PHASE3
Secukinumab for Treatment of Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
Measuring Consequences of Disability for Patients With Multiple Sclerosis and Caregivers on Economic Burden
- Status
- COMPLETED
- Phase
- N/A
Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention
- Status
- COMPLETED
- Phase
- PHASE2